143 related articles for article (PubMed ID: 7378257)
1. Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Anttila M; Sundqvist H
Br J Clin Pharmacol; 1980 Apr; 9(4):399-405. PubMed ID: 7378257
[TBL] [Abstract][Full Text] [Related]
2. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
Aro A; Anttila M; Korhonen T; Sundquist H
Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
[TBL] [Abstract][Full Text] [Related]
4. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
5. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
7. Propranolol and sotalol metabolism after a drinking party.
Sotaniemi EA; Anttila M; Rautio A; Stengård J; Saukko P; Järvensivu P
Clin Pharmacol Ther; 1981 Jun; 29(6):705-10. PubMed ID: 7226702
[TBL] [Abstract][Full Text] [Related]
8. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
[TBL] [Abstract][Full Text] [Related]
9. Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker.
Säkö S; Sotaniemi EA; Anttila M
Eur J Drug Metab Pharmacokinet; 1986; 11(2):81-6. PubMed ID: 3770017
[TBL] [Abstract][Full Text] [Related]
10. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
11. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
12. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
Reilly CS; Biollaz J; Koshakji RP; Wood AJ
Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
Traeger A; Horváth T; Rechenbach C; Jávor T
Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
[TBL] [Abstract][Full Text] [Related]
14. Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.
Erkkola R; Lammintausta R; Liukko P; Anttila M
Acta Obstet Gynecol Scand; 1982; 61(1):31-4. PubMed ID: 7046334
[TBL] [Abstract][Full Text] [Related]
15. Reduction of liver blood flow and propranolol metabolism by cimetidine.
Feely J; Wilkinson GR; Wood AJ
N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
[TBL] [Abstract][Full Text] [Related]
16. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
18. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
[TBL] [Abstract][Full Text] [Related]
19. Liver size and indices of drug metabolism in epileptics.
Pirttiaho HI; Sotaniemi EA; Ahokas JT; Pitkänen U
Br J Clin Pharmacol; 1978 Sep; 6(3):273-8. PubMed ID: 687506
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
